INVESTMENT HIGHLIGHTS

Exciting medical devices company founded by Melbourne University scientists.

Company at forefront of developing a world-first, revolutionary rapid diagnostic devices using proprietary technology.

Products range from rapid Covid-19 test, to STD tests and cancer biomarker tests, with wide range of medical applications.

Company looking to partner with investors and/or industry professionals to launch its products in the US, EU, Asia and Australia.

Company already received two rounds of financing from professional investors and looking to invite investors to participate in the 3rd round of financing.

Company’s first Covid-19 rapid test already undergoing trials in the US. Its STD rapid trials to follow in 2nd half of 2021.

Suit high net worth, sophisticated investors including family offices, medical professionals interested in high-growth, high-tech exposure, with massive upside potential.

For more details, please email broker or call agents.